An antiosteoporotic agent
Technical Support & Resources

Information provided in the product description is from published literature. Due to the nature of scientific experimentation, your results (e.g., selectivity and effective concentrations) or specific application for this product may differ. If you have questions about how this product fits your application, please contact our technical support staff.

Visit our FAQ

Contact Us

Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888

Request Technical Support

Technical Support Request

To streamline the process attach the appropriate questionnaire to your inquiry.

Download IHC QuestionnaireDownload WB Questionnaire

View Our Privacy Statement for details on how we use and protect your data. In addition, this site is protected by hCaptcha and its Privacy Policy and Terms of Service apply.

Product Categories

Product Type

Strontium Ranelate

Item No. 30272

Technical Information
Formal Name
5-[bis(carboxymethyl)amino]-2-carboxy-4-cyano-3-thiopheneacetic acid, distrontium salt
CAS Number
135459-87-9
Synonyms
  • S12911
  • S12911-2
Molecular Formula
C12H6N2O8S • 2Sr
Formula Weight
Purity
≥98%
A crystalline solid
PBS (pH 7.2): 2 mg/ml
λmax
214, 234, 324 nm
SMILES
[O-]C(CN(CC([O-])=O)C1=C(C#N)C(CC([O-])=O)=C(C([O-])=O)S1)=O.[Sr+2].[Sr+2]
InChi Code
InChI=1S/C12H10N2O8S.2Sr/c13-2-6-5(1-7(15)16)10(12(21)22)23-11(6)14(3-8(17)18)4-9(19)20;;/h1,3-4H2,(H,15,16)(H,17,18)(H,19,20)(H,21,22);;/q;2*+2/p-4
InChi Key
XXUZFRDUEGQHOV-UHFFFAOYSA-J
Shipping & Storage Information
Storage
-20°C
Shipping
Room temperature in continental US; may vary elsewhere
Recommended Products

Certificates of Analysis & Batch Specific Data

Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.

    Add

    Add

    Add

    Add

    Product Description

    Strontium ranelate is an antiosteoporotic agent.1 It inhibits 1,25-dihydroxyvitamin D3-induced increases in the levels of carbonic anhydrase II and the vitronectin receptor, markers of osteoclast differentiation, in isolated chicken bone marrow cells when used at concentrations of 0.1, 0.5, and 1 mM. Pretreatment or continuous treatment of bovine bone slices with strontium ranelate (1 mM) inhibits bone resorption by isolated rat osteoclasts. Strontium ranelate (750 mg/kg per day) decreases osteoclast surface and number, indicating inhibition of bone resorption, but has no effect on the bone formation rate or mineral apposition rate, indicating maintenance of bone formation, in the alveolar bone in adult cynomolgus monkeys.2

    WARNING This product is not for human or veterinary use.

    References & Product Citations
    Product Description References

    1. Baron, R., and Tsouderos, Y. In vitro effects of S12911-2 on osteoclast function and bone marrow macrophage differentiation. Eur. J. Pharmacol. 450(1), 11-17 (2002).

    2. Buehler, J., Chappuis, P., Saffar, J.L., et al. Strontium ranelate inhibits bone resorption while maintaining bone formation in alveolar bone in monkeys (Macaca fascicularis). Bone 29(2), 176-179 (2001).